Search Results

The Normal Hematocrit Cardiac Trial Revisited

Author: Goodkin, David A.

Source: Seminars in Dialysis, Volume 22, Number 5, September/October 2009 , pp. 495-502(8)

Publisher: Blackwell Publishing

Erythropoiesis-stimulating agents in patients with cancer: update on safety issues

Author: Pirker, Robert

Source: Expert Opinion on Drug Safety, Volume 8, Number 5, September 2009 , pp. 515-522(8)

Publisher: Informa Healthcare

Use of erythropoiesis stimulating agents for the treatment of anaemia and related fatigue in a pregnant woman with HbH disease

Authors: Macciò, Antonio; Madeddu, Clelia; Chessa, Paola; Mantovani, Giovanni; Galanello, Renzo

Source: British Journal of Haematology, Volume 146, Number 3, August 2009 , pp. 335-337(3)

Publisher: Blackwell Publishing

Erythropoietic-stimulating agents: the cancer progression controversy and collateral damage to the blood supply

Source: Transfusion, Volume 49, Number 5, May 2009 , pp. 824-826(3)

Publisher: Blackwell Publishing

Correlates affecting survival in chronic hemodialysis patients: The combined impact of albumin and high hemoglobin levels on improving outcomes, local and national results

Authors: CAPELLI, John P.; KUSHNER, Harvey

Source: Hemodialysis International, Volume 12, Number 4, October 2008 , pp. 450-462(13)

Publisher: Blackwell Publishing

RECOMBINANT HUMAN ERYTHROPOIETIN BETA THERAPY: An Effective Strategy to Reduce Transfusion Requirement in Children Receiving Anticancer Treatment

Authors: Corapcioglu, Funda; Aksu, Gorkem; Basar, Evic; Demirel, Atalay; Oncel, Selim; Mutlu, Ajda

Source: Pediatric Hematology and Oncology, Volume 25, Number 6, August 2008 , pp. 509-521(13)

Publisher: Informa Healthcare

Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysis

Authors: Moyo, Victor; Lefebvre, Patrick; Duh, Mei; Yektashenas, Behin; Mundle, Suneel

Source: Annals of Hematology, Volume 87, Number 7, July 2008 , pp. 527-536(10)

Publisher: Springer

Pharmacodynamic model for chemotherapy-induced anemia in rats

Authors: Woo, Sukyung; Krzyzanski, Wojciech; Jusko, William

Source: Cancer Chemotherapy and Pharmacology, Volume 62, Number 1, June 2008 , pp. 123-133(11)

Publisher: Springer

Thrombosis with Erythropoietic Stimulating Agents—Does Iron-Deficient Erythropoiesis Play a Role?

Authors: Dahl, Naomi V.; Henry, David H.; Coyne, Daniel W.

Source: Seminars in Dialysis, Volume 21, Number 3, May/June 2008 , pp. 210-211(2)

Publisher: Blackwell Publishing

Role of Erythropoietin in Cancer-related Anaemia: a Double-edged Sword?

Authors: Guan, X.; Chen, L.

Source: The Journal of International Medical Research, Volume 36, Number 1, January 2008 , pp. 1-8(8)

Publisher: Field House Publishing

Darbepoetin alfa for chemotherapy-induced anemia: evolution to extended dosing intervals

Authors: Vansteenkiste, Johan; Wauters, Isabelle

Source: Expert Review of Anticancer Therapy, Volume 7, Number 10, October 2007 , pp. 1347-1355(9)

Publisher: Expert Reviews

Erythropoietic growth factors for children with cancer: a systematic review of the literature

Authors: Mystakidou, Kyriaki; Potamianou, Anna; Tsilika, Eleni

Source: Current Medical Research and Opinion, Volume 23, Number 11, November 2007 , pp. 2841-2847(7)

Publisher: Informa Healthcare

Speed of haemoglobin response in patients with cancer: a review of the erythropoietic proteins

Author: Oberhoff, Carsten

Source: Supportive Care in Cancer, Volume 15, Number 6, June 2007 , pp. 603-611(9)

Publisher: Springer

Dosing patterns, drug costs, and hematologic outcome in anemic patients with chronic kidney disease switching from darbepoetin alfa to epoetin alfa

Authors: Hymes, Jeffrey; Bickimer, Tammy; Jackson, James H.; Bookhart, Brahim K.; Mody, Samir H.; Tak Piech, Catherine

Source: Current Medical Research and Opinion, Volume 23, Number 8, August 2007 , pp. 1931-1937(7)

Publisher: Informa Healthcare

Iron therapy for renal anemia: how much needed, how much harmful?

Author: Hörl, Walter

Source: Pediatric Nephrology, Volume 22, Number 4, April 2007 , pp. 480-489(10)

Publisher: Springer

Guidelines and Recommendations for the Management of Anaemia in Patients with Lymphoid Malignancies

Author: Henry, David H.

Source: Drugs, Volume 67, Number 2, 2007 , pp. 175-194(20)

Publisher: Adis International

Effectiveness versus convenience: patient preferences for an erythropoietic agent to treat cancer-related anemia

Authors: Langer, Corey J.; Fastenau, John M.; Forlenza, Jamie B.; Tak Piech, Catherine; Bolge, Susan C.; Gano Allen, Jennifer; Zilberberg, Marya D.

Source: Current Medical Research and Opinion, Volume 23, Number 1, January 2007 , pp. 85-92(8)

Publisher: Informa Healthcare

Dosing Patterns and Treatment Costs of Erythropoietic Agents in Elderly Patients with Pre-Dialysis Chronic Kidney Disease in Managed Care Organisations

Authors: Mei Sheng Duh,; Mody, Samir H.; McKenzie, R. Scott; Lefebvre, Patrick; Gosselin, Antoine; Bookhart, Brahim K.; Catherine Tak Piech,

Source: Drugs & Aging, Volume 23, Number 12, 2006 , pp. 969-976(8)

Publisher: Adis International

Impact and treatment of anemia in the elderly: clinical, epidemiological and economic perspectives

Authors: Duh, Mei Sheng; Latypova, Alexandra; Greenberg, Paul

Source: Expert Review of Pharmacoeconomics and Outcomes Research, Volume 6, Number 5, October 2006 , pp. 577-590(14)

Publisher: Expert Reviews

Spotlight on Darbepoetin Alfa in the Treatment of Anemia in Patients with Cancer Receiving Chemotherapy

Authors: Siddiqui, M. Asif A.; Keating, Gillian M.

Source: BioDrugs, Volume 20, Number 5, 2006 , pp. 321-323(3)

Publisher: Adis International